Start your own journey to clinic

Please provide us with a few details so that we can match you with the right expert in your field.


Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at

Target Validation

Target identification and validation are the first stages in the drug discovery process, serving as the foundation for the development of novel therapeutic agents. Target identification involves the identification of specific biological molecules or pathways that play a key role in a disease process and could be potential targets for drug intervention. This step often involves a combination of approaches, including genomics, proteomics, and bioinformatics, to pinpoint the biological components associated with a particular disease. Understanding the underlying molecular mechanisms of a disease is crucial for selecting appropriate targets that can be modulated to achieve a therapeutic effect. Following target identification, the next crucial step is target validation, which aims to confirm the relevance of the selected targets in the context of the disease and assess their suitability for drug development. This process involves rigorous experimentation to demonstrate the causal relationship between the target and the disease phenotype. Various experimental techniques, such as genetic manipulation, biochemical assays, and animal models, are employed to validate the potential targets. Successful validation provides confidence that modulating the target will indeed have the desired therapeutic effect, reducing the risk of investing resources in drug development programs that may not yield effective treatments.

Connected servicesMore informationSpeak to an expert

Connected expertise and services

Connected expertise and services

A more in-depth view

Connected resources